FDA approves Gilead's remdesivir as coronavirus treatment

The U.S. Food and Drug Administration has officially approved remdesivir as a treatment for coronavirus, drug manufacturer Gilead Sciences announced Thursday.The Ebola drug was already being used to treat patients under an emergency-use authorization issued in May, but the latest FDA action makes it “the first and only approved COVID-19 treatment” in the United States, according to the company.The antiviral drug has been found to reduce recovery time by an average of five days among those who are sick enough to be hospitalized. Also known by the brand name Veklury, the drug can fast-track reco…

Read More

HEDGE accordingly